Evidence mapPaperPMID 40733247Full record

ReviewMolecules (Basel, Switzerland)2025

Bioactive Compounds as Modulators of N-Formyl Peptide Signaling in Chronic Diseases.

Livia Alvarenga, Ludmila F M F Cardozo, Márcia Ribeiro, Fernanda Kussi, Marta Esgalhado, Denise Mafra

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Livia AlvarengaDepartment of Cardiopneumology, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo 01246-903, SP, Brazil.
Ludmila F M F CardozoGraduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói 24020-140, RJ, Brazil.ORCID 0000-0001-8507-2369
Márcia RibeiroGraduate Program in Biological Sciences-Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, RJ, Brazil.
Fernanda KussiDepartment of Basic Pathology, Federal University of Paraná, Curitiba 81531-980, PR, Brazil.ORCID 0000-0001-7889-2748
Marta EsgalhadoCBIOS-Universidade Lusófona's Research Center for Biosciences and Health Technologies, 1749-024 Lisbon, Portugal.ORCID 0000-0002-0370-5175
Denise MafraGraduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói 24020-140, RJ, Brazil.ORCID 0000-0001-6752-6056

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In physiological situations involving cell damage, molecules derived from mitochondria or bacteria are produced. These molecules are known as N-formyl peptides and are detected by formyl peptide receptors (FPRs), which stimulate immune cells to migrate to the specific site of injury or infection. Despite their initially beneficial effects on health, N-formyl peptides also contribute to the development or exacerbation of chronic non-communicable diseases. Therefore, understanding the metabolic pathways related to the involvement of N-formyl peptides and FPRs may increase our ability to regulate immune responses and precisely target FPRs with personalized strategies, offering a promising approach for the treatment of specific diseases. In this way, bioactive compounds in food may influence N-formyl peptides, interacting with the receptors either competitively or by inhibiting them, which affects the inflammatory response and oxidative reactions of cells. This review examines the pathways associated with forming N-formyl peptides, the activation of FPRs, and the roles of bioactive compounds in regulating N-formyl peptides.

Indexed as

Receptors, Formyl PeptideSignal TransductionAnimalsChronic DiseaseHumansReceptors, Formyl Peptidebioactive compoundsdietformyl peptide receptorsN-formyl peptidesnon-communicable disease

Identifiers

PMID40733247
PMCPMC12298040

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.